Cisatracurium Besylate
- Product NDC
- 25021-670
- 11-digit product format
- 250210670
- Labeler code
- 25021
- Product ID
- 25021-670_507a0145-c6e8-4dcc-8199-3d0674517939
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- cisatracurium besylate
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Sagent Pharmaceuticals
- Application
- ANDA201851
- Marketing category
- ANDA
- Marketing start
- 2021-11-01
- Marketing end
- 0000-00-00
- Substance
- CISATRACURIUM BESYLATE
- Active strength
- 2 mg/mL
- Pharmacologic classes
- Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 25021-670-10 | 25021067010 | 10 VIAL in 1 CARTON (25021-670-10) > 10 mL in 1 VIAL | 10 vial | 2021-11-01 | 0000-00-00 | No | No | Current |